Athanasios N. Papadopoulos

Prof. Dr. Athanasios N. Papadopoulos

Department of Nutritional Sciences and Dietetics, International Hellenic University (IHU), 57400 Thessaloniki, Greece
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MSMaria John Spanoudaki
Maria John Spanoudaki
CONSTANTINOS GIAGINISCONSTANTINOS GIAGINIS
CONSTANTINOS GIAGINIS
DKDimitra Karafyllaki
Dimitra Karafyllaki
KPKonstantinos Papadopoulos
Konstantinos Papadopoulos
ESEvangelos Solovoa
Evangelos Solovoa
Sousana PapadopoulouSousana Papadopoulou
Sousana Papadopoulou
Background: Cancer cases are continuously increasing, while the prevalence rates of physical inactivity are also continuously increasing. Physical inactivity is a causative factor in non-communicable diseases, including cancer. However, the potential beneficial effects of exercise on cancer treatment have not received much attention so far. The aim of this study was to highlight the relationship between cancer and exercise on a molecular basis. Methods: Comprehensive and in-depth research was conducted in the most accurate scientific databases by using relevant and effective keywords. Results: The mechanisms by which exercise may reduce cancer risk and/or progression may include the metabolic profile of hormones, systemic inflammation reduction, insulin sensitivity increase, antioxidant capacity augmentation, the boost to the immune system, and the direct effect on the tumor. There is currently substantial evidence that the effect of exercise may predict a stronger association with cancer and could supplementarily be embedded in cancer clinical practice to improve disease progression and prognosis. Conclusion: The field of this study requires interconnecting the overall knowledge of exercise physiology with cancer biology and cancer clinical oncology to provide the basis for personalized targeting strategies that can be merged with training as a component of a holistic co-treatment approach to optimize cancer healthcare.

11 January 2018 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
ATAna Tadić
Ana Tadić
JPJelena Poljarević
Jelena Poljarević
MKMilena Krstić
Milena Krstić
MKMarijana Kajzerberger
Marijana Kajzerberger
SASandra Arandelovic
Sandra Arandelovic
SGSanja Grgurić-Šipka
Sanja Grgurić-Šipka
Two non-steroidal antiinflammatory drugs indomethacin and mefenamic acid were coordinated to Ru(II)–arenes to afford four new complexes. The cytotoxic activities of the ligands and ruthenium complexes were tested in three human cancer cell lines (K562, A549, MDA-MB-231) and non-tumour human fetal lung fibroblast cells (MRC-5) by MTT assay. Cytotoxicity studies revealed that indomethacin Ru(II)–arene complexes 1 and 3 displayed good cytotoxicity and apparent cytoselective profiles. The IC50 values obtained in leukemia K562 cells were comparable to those of cisplatin (10.3 μM (CDDP), 11.9 μM (1) and 13.2 μM (3)). Flow cytometric analysis of 1 and 3 in triple-negative breast cancer MDA-MB-231 cells revealed an interesting mechanism of action. At IC50 concentrations, 1 and 3 arrested cell cycle progression in S phase and caused rapid accumulation of cells in sub-G1 phase (up to 48%), while Annexin V-FITC/PI staining showed simultaneous occurrence of apoptotic and necrotic cell populations at approximately similar levels of 20%. Measurement of reactive oxygen species (ROS) production by DCFH-DA staining confirmed the potential of 1 and 3 to increase ROS even more than cisplatin. The interaction of the complexes with serum albumins showed their potential ability to bind tightly and reversibly to albumins. The affinity of the complexes to calf-thymus DNA was investigated by UV-vis spectroscopy, viscosity measurements and fluorescence emission spectroscopy for competitive studies of the complexes with ethidium bromide, revealing that their interaction probably occurs via intercalation. Taken together, the results strongly suggest the potential of complexes 1 and 3 to alter cell cycle progression and cause DNA-damage by means of direct DNA-binding or indirectly by ROS production.

24 May 2023 in Life
Verified
Journal Article
Open access
PDF file
MSMaria Spanoudaki
Maria Spanoudaki
CONSTANTINOS GIAGINISCONSTANTINOS GIAGINIS
CONSTANTINOS GIAGINIS
MMMaria Mentzelou
Maria Mentzelou
ABAlexia Bisbinas
Alexia Bisbinas
ESEvangelos Solovos
Evangelos Solovos
Sousana PapadopoulouSousana Papadopoulou
Sousana Papadopoulou
Aging is a physical procedure for people and nature. Our aging world is expanding because of the life span extension. Aging has a crucial relationship with our body composition (muscles, bones, and adipose tissue), which is characterized by an increase in fat mass and a gradual decrease in muscle mass and strength and bone density. These alterations affect physical performance and impact quality of life enhancing the risk for non-communicable diseases, immobilization, and disability. As far we know, osteoarthritis of lower limbs, sarcopenic obesity, and muscle mass and/or strength loss are treated separately. However, bones, muscles, adipose tissue, and aging appear to have an interconnection through a dialogue as they talk to each other. Health disorders are coming into the surface when this relationship is disrupted. The aim of our study is to search deeper into this interconnection, so that when adipose tissue increases, we have to take a look into the condition of muscle mass, bone, and connective tissue and vice versa, through the assessment of physical performance. Consequently, the triad muscle-bone-adipose tissue disorders by aging should be treated as a single entity.

1 December 2017 in Polyhedron
Verified
Journal Article
Closed access
SPSpyros Perontsis
Spyros Perontsis
ATAlexia Tialiou
Alexia Tialiou
AHAntonios Hatzidimitriou
Antonios Hatzidimitriou
APAthanasios N. Papadopoulos
Athanasios N. Papadopoulos
GPGeorge Psomas
George Psomas

7 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
NATASA KALOGIOURINATASA KALOGIOURI
NATASA KALOGIOURI
PMPetros Mitsikaris
Petros Mitsikaris
Dimitris KlaoudatosDimitris Klaoudatos
Dimitris Klaoudatos
APAthanasios N. Papadopoulos
Athanasios N. Papadopoulos
Victoria SamanidouVictoria Samanidou
Victoria Samanidou
Reversed phase-high-pressure liquid chromatographic methodologies equipped with UV detector (RP-HPLC-UV) were developed for the determination of phenolic compounds and tocopherols in almonds. Nineteen samples of Texas almonds originating from USA and Greece were analyzed and 7 phenolic acids, 7 flavonoids, and tocopherols (−α, −β + γ) were determined. The analytical methodologies were validated and presented excellent linearity (r2 > 0.99), high recoveries over the range between 83.1 (syringic acid) to 95.5% (ferulic acid) for within-day assay (n = 6), and between 90.2 (diosmin) to 103.4% (rosmarinic acid) for between-day assay (n = 3 × 3), for phenolic compounds, and between 95.1 and 100.4% for within-day assay (n = 6), and between 93.2–96.2% for between-day assay (n = 3 × 3) for tocopherols. The analytes were further quantified, and the results were analyzed by principal component analysis (PCA), and agglomerative hierarchical clustering (AHC) to investigate potential differences between the bioactive content of almonds and the geographical origin. A decision tree (DT) was developed for the prediction of the geographical origin of almonds proposing a characteristic marker with a concentration threshold, proving to be a promising and reliable tool for the guarantee of the authenticity of the almonds.

Verified
Journal Article
Open access
PDF file
FDFilitsa Dimiza
Filitsa Dimiza
ABAmalia Barmpa
Amalia Barmpa
ACAntonios Chronakis
Antonios Chronakis
AHAntonios Hatzidimitriou
Antonios Hatzidimitriou
YSYiannis Sanakis
Yiannis Sanakis
GPGeorge Psomas
George Psomas
One the main research goals of bioinorganic chemists is the synthesis of novel coordination compounds possessing biological potency. Within this context, three novel iron(III) complexes with the non-steroidal anti-inflammatory drugs diflunisal and diclofenac in the presence or absence of the nitrogen donors 1,10-phenanthroline or pyridine were isolated and characterized by diverse techniques. The complexes were evaluated for their ability to scavenge in vitro free radicals such as hydroxyl, 1,1-diphenyl-2-picrylhydrazyl and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radicals, revealing their selective potency towards hydroxyl radicals. The in vitro inhibitory activity of the complexes towards the enzymes acetylcholinesterase and butyrylcholinesterase was evaluated, and their potential to achieve neuroprotection appeared promising. The interaction of the complexes with calf-thymus DNA was examined in vitro, revealing their ability to intercalate in-between DNA nucleobases. The affinity of the complexes for serum albumins was evaluated in vitro and revealed their tight and reversible binding.